The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cachexia is an independent factor for negative clinical and functional outcomes in lymphoma patients receiving CART therapy.
 
Ishan Roy
No Relationships to Disclose
 
Gordon John Smilnak
No Relationships to Disclose
 
Madelyn Burkart
No Relationships to Disclose
 
Corinne Williams
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - AstraZeneca
 
Elizabeth Hamilton
No Relationships to Disclose
 
Sarah Miyata
No Relationships to Disclose
 
Katherine Thorp
No Relationships to Disclose
 
Shuo Ma
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Bioverativ; Genentech; Gilead Sciences; Janssen; Kite, a Gilead company; Pharmacyclics
Speakers' Bureau - AstraZeneca; BeiGene
Research Funding - Abbvie; AstraZeneca; BeiGene; Janssen; Juno Therapeutics; Novartis; Pharmacyclics; TG Therapeutics
 
Jane N. Winter
Consulting or Advisory Role - Agios (I); Ariad (I); Bristol-Myers Squibb (I); CVS Caremark (I); Epizyme (I); Janssen (I); Karyopharm Therapeutics; Merck; Novartis (I); Novartis (I); Takeda (I)
Research Funding - Astellas Pharma (Inst); Celgene (I); Curis; Daiichi Sankyo (I); ERYTECH Pharma (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Merck
Patents, Royalties, Other Intellectual Property - Royalties from UptoDate, Inc. (I)
Travel, Accommodations, Expenses - Adicet Bio; Bayer; Gilead Sciences; Janssen; Merck
 
Barbara Pro
Honoraria - Bayer; Celgene; kiowa; Portola Pharmaceuticals; Seagen; Takeda
Consulting or Advisory Role - Corvus Pharmaceuticals
Research Funding - Celgene (Inst); takeda (Inst); verastem
Travel, Accommodations, Expenses - Seagen; takeda
 
Leo I. Gordon
Research Funding - Bristol-Myers Squibb; Juno/Celgene
 
Reem Karmali
Honoraria - Bio Ascend; Prime Oncology
Consulting or Advisory Role - Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite/Gilead; Morphosys
Speakers' Bureau - AstraZeneca; BeiGene; Kite/Gilead
Research Funding - Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Juno Therapeutics (Inst); MedImmune (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Prime Oncology